Gluten Sensitivity Clinical Trials
3 recruiting trials for Gluten Sensitivity. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Gluten Sensitivity clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Palermo (1), Boston Children's Hospital (1), Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Open wheat challenge (other, 1 trial), followed by Placebo challenge, Gluten Powder.
Track Gluten Sensitivity trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Dietary Approach to Mild-to-moderate Psoriasis
Psoriasis is a systemic chronic inflammatory immune-mediated disease whose etiopathogenetic mechanisms involve genetic predisposition, and immunological and environmental factors....
Immune Responses to Gluten
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease
This study investigates how the immune system of children with celiac disease responds to controlled, small amounts of gluten. Children on a strict gluten-free diet are randomly...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Gluten Sensitivity, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Gluten Sensitivity, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Gluten Sensitivity, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.